G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2011
10/13/2011	WO2011126740A2 Hip1 cancer markers
10/13/2011	WO2011126482A1 Immunoassay for the diagnosis of prostate cancer
10/13/2011	WO2011126387A1 Method for differentiating the early rheumatoid arthritis from other rheumatic diseases
10/13/2011	WO2011126385A2 Assay system
10/13/2011	WO2011126332A2 Method for determining age of ginseng roots using chromatography-mass spectroscopy
10/13/2011	WO2011126249A2 Chip for fluid analysis wherein fluid moves without external power
10/13/2011	WO2011126183A1 Apparatus and method for determining protein secondary structure by using coordinate information of alpha carbons
10/13/2011	WO2011126126A1 NON-HUMAN ANIMAL DEFICIENT IN Gm1 GENE PRODUCT AND METHOD OF UTILIZATION THEREOF
10/13/2011	WO2011126105A1 Test method for determining susceptibility to or state of immune system disorder or joint disorder
10/13/2011	WO2011126089A1 Method of detecting rhabdomyosarcoma using sample derived from body fluid
10/13/2011	WO2011126067A1 Method of measuring glycated hemoglobin
10/13/2011	WO2011126053A1 Method for examining digestive cancer using n-binding sugar chains
10/13/2011	WO2011125917A1 Method for generating data set for integrated proteomics, integrated proteomics method using data set for integrated proteomics that is generated by the generation method, and method for identifying causative substance using same
10/13/2011	WO2011125912A1 Method for reducing interference by component outside assay system
10/13/2011	WO2011125877A1 Measurement method using immunochromatography, test strip for immunochromatography, and measurement reagent kit for immunochromatography
10/13/2011	WO2011125875A1 Novel monoclonal antibody and method for immunoassaying d dimer
10/13/2011	WO2011125873A1 Method for avoiding influence of endogenous lipoprotein and reagent
10/13/2011	WO2011125872A1 Reagent for assaying anti-treponema pallidum antibody
10/13/2011	WO2011125871A1 Method for stabilizing glycerophospholipids and reagents using same
10/13/2011	WO2011125858A1 Biomarkers
10/13/2011	WO2011125852A1 Nucleic acid structure, method for producing complex using same, and screening method
10/13/2011	WO2011125606A1 Conjugate for measuring polyvalent antigen, immunochromatographic test strip for measuring polyvalent antigen using same, and immunochromatographic measurement method
10/13/2011	WO2011125600A1 Method and device for cell activation
10/13/2011	WO2011125458A1 Marker for diagnosing effect of anticancer agent
10/13/2011	WO2011125321A1 Array for detecting biological substance, assay system and assay method
10/13/2011	WO2011125033A1 Method for detecting clusters of biological particles
10/13/2011	WO2011125012A1 Biomarkers for p13k-driven cancer
10/13/2011	WO2011124945A1 Detector for detecting contaminants in water or aqueous solutions
10/13/2011	WO2011124927A1 Method of analysing a cell or other biological material containing a nucleic acid
10/13/2011	WO2011124906A1 Sampling plate
10/13/2011	WO2011124376A1 New formulations for diagnosis of alzheimer's disease
10/13/2011	WO2011123903A1 Chemokine receptor heteromultimers, compounds that bind thereto and uses thereof
10/13/2011	WO2011095888A3 Method and rapid test device for detection of target molecule
10/13/2011	WO2011088391A3 Predicting and reducing alloimmunogenicity of protein therapeutics
10/13/2011	WO2011084641A3 Gold coating of rare earth nano-phosphors and uses thereof
10/13/2011	WO2011075614A3 Portable coagulation monitoring device and method of assessing coagulation response
10/13/2011	WO2011073746A3 Calibration of electrochemical sensor
10/13/2011	WO2011072197A9 Detection of oxidized polypeptides
10/13/2011	WO2011071343A3 Heterodimer core-shell nanoparticle in which raman-active molecules are located at a binding portion of a nanoparticle heterodimer, use thereof, and method for preparing same
10/13/2011	WO2011070578A3 Acoustic explosive detection device and method
10/13/2011	WO2011069029A3 Lateral flow assays
10/13/2011	WO2011068764A3 Apparatuses, systems, methods, and computer readable media for acoustic flow cytometry
10/13/2011	WO2011063235A3 Peptides, devices, and methods for the detection of ehrlichia antibodies
10/13/2011	WO2011061632A3 Grey water diversion system
10/13/2011	WO2011052906A3 Use of eif3m for the diagnosis and treatment of cancer
10/13/2011	WO2011049412A3 Human recombinant monoclonal antibody that specifically binds to vcam-1 and inhibits adhesion and transmigration between leukocytes and endothelial cells
10/13/2011	WO2011047794A3 Medical utility of glycan-binding proteins and glycans
10/13/2011	WO2011036666A3 Systems and methods for measuring translation of target proteins in cells
10/13/2011	WO2011016031A3 Urinary biomarkers for cancer diagnosis
10/13/2011	WO2011008907A3 Method for estimating properties of concrete
10/13/2011	WO2010128506A3 Means and methods for recognizing the development of cardiovascular disease in an individual
10/13/2011	WO2010106331A8 Mass-sensitive sensor comprising immobilised cells on its surface and method of detecting ligand binding making use of the sensor
10/13/2011	WO2009065508A3 Water-soluble rylene dyes, methods for preparing the same and uses thereof as fluorescent labels for biomolecules
10/13/2011	US20110252510 Soybean Plant and Seed Corresponding to Transgenic Event MON87754 and Methods for Detection Thereof
10/13/2011	US20110252509 Method for Producing a Transgenic Cell with Increased Gamma-Aminobutyric Acid (Gaba) Content
10/13/2011	US20110252487 Composition for inducing th2 cell, therapeutic composition for th2-type disease, and use of same
10/13/2011	US20110251983 Methods for the survey and genetic analysis of populations
10/13/2011	US20110251856 Health monitoring and diagnostic device and network-based health assessment and medical records maintenance system
10/13/2011	US20110251376 Mammalian Tumor Susceptibility Genes and their Uses
10/13/2011	US20110251272 Methods and compositions for predicting drug responses
10/13/2011	US20110251266 Aptamer for ngf and use thereof
10/13/2011	US20110251246 Small molecule inhibitors of muc1 and methods of identifying the same
10/13/2011	US20110251238 Ppar agonist compositions and methods of use
10/13/2011	US20110251113 Lubricating grease compositions
10/13/2011	US20110251105 Methods for detecting target analytes and enzymatic reactions
10/13/2011	US20110251097 Diagnostic kit of colon cancer using colon cancer related marker and diagnostic method thereof
10/13/2011	US20110251096 Health Test for a Broad Spectrum of Health Problems
10/13/2011	US20110251095 Mara family helix-turn-helix domains and their methods of use
10/13/2011	US20110251094 Biomarkers for hypertensive disorders of pregnancy
10/13/2011	US20110251090 Pancreatic cancer related gene ttll4
10/13/2011	US20110251087 Prognostic and diagnostic method for cancer therapy
10/13/2011	US20110251086 Neuroblastoma prognostic multigene expression signature
10/13/2011	US20110251081 Methods and compositions for determining gene function
10/13/2011	US20110251076 Non-invasive detection of fetal genetic traits
10/13/2011	US20110251075 System and method for the analysis of bodily fluids
10/13/2011	US20110250705 Nanopore capture system
10/13/2011	US20110250704 Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification
10/13/2011	US20110250703 Il1rl-1 as a cardiovascular disease marker and therapeutic target
10/13/2011	US20110250702 Isolated peptides of rabbit factor vii
10/13/2011	US20110250701 Novel application of aimp1 polypeptide
10/13/2011	US20110250700 Methods for Sequencing Individual Nucleic Acids Under Tension
10/13/2011	US20110250699 Fluorescent Dye Compounds, Conjugates and Uses Thereof
10/13/2011	US20110250698 Methods of nucleic acid target capture
10/13/2011	US20110250697 Non-naturally occurring dna sequences
10/13/2011	US20110250696 Process for High Concentration Cation Exchange Metathesis
10/13/2011	US20110250695 Method, structure, device, kit and system for the automated analysis of liquid samples
10/13/2011	US20110250669 Method and apparatus for selectively targeting specific cells within a cell population
10/13/2011	US20110250641 Zwitterionic acid-labile surfactants and methods of use
10/13/2011	US20110250630 Motif-grafted hybrid polypeptides and uses thereof
10/13/2011	US20110250625 Gamma secretase notch biomarkers
10/13/2011	US20110250624 Elisa assay for detecting antibodies against blv surface antigen gp 51 in bovine serum
10/13/2011	US20110250623 Biomarker and method for detecting a chronic inflammatory-associated disease
10/13/2011	US20110250622 Method for diagnosing auto-immune chronic urticaria
10/13/2011	US20110250621 Method for in vitro assay of the circulating tissue factor, and use in the detection of coagulation diseases
10/13/2011	US20110250620 Methods of evaluating an immune response to an antigen
10/13/2011	US20110250619 Methods of Detecting Antibodies Specific for Denatured HLA Antigens
10/13/2011	US20110250618 Biomarkers and assays for diabetes
10/13/2011	US20110250616 Electroactive surface-confinable molecules
10/13/2011	US20110250615 Methods and Compositions for Detection of Ehrlichia chaffeensis (VLPT)
10/13/2011	US20110250614 Methods and compositions for detecting the activation state of multiple proteins in single cells

1 ... 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 ... 3937